These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4586057)

  • 1. Editorial: Rifampicin or ethambutol in the routine treatment of tuberculosis.
    Br Med J; 1973 Dec; 4(5892):568. PubMed ID: 4586057
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination therapy of pulmonary tuberculosis using rifampicin and ethambutol].
    Haegi V
    Helv Med Acta Suppl; 1969; 49():81-7. PubMed ID: 5267584
    [No Abstract]   [Full Text] [Related]  

  • 3. [Rifampicin and ethambutol combination in the treatment of pulmonary tuberculosis. Partial results].
    Ennes Filho E; Azevedo DE; Sayeg F
    Rev Bras Med; 1971 Apr; 28(4):171-9. PubMed ID: 5120854
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 5. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
    Girling DJ
    Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of treatment of patients with destructive forms of pulmonary tuberculosis with rifampicin and ethambutol].
    Mavrotskiĭ VV
    Klin Med (Mosk); 1974 Dec; 52(12):31-4. PubMed ID: 4444241
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of clinical studies with capreomycin, ethambutol and rifampicin in the Heckeshorn Hospital, Berlin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1969; 69():43-53. PubMed ID: 4906373
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical effect of rifampicin-ethambutol isoniazid on untreated pulmonary tuberculosis.
    Konno K; Oizumi K; Yamada S; Ogata K; Sato M
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):68-72. PubMed ID: 4649624
    [No Abstract]   [Full Text] [Related]  

  • 9. [Side effects in strictly supervised treatment with rifampicin and ethambutol].
    Năstase M; Năstase R; Brener E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):241-3. PubMed ID: 174182
    [No Abstract]   [Full Text] [Related]  

  • 10. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 11. Ethambutol compared to rifampin in original treatment of pulmonary tuberculosis.
    Bobrowitz ID
    Lung; 1980; 157(3):117-25. PubMed ID: 7382540
    [No Abstract]   [Full Text] [Related]  

  • 12. [Proceedings: Rifampicin in initial therapy of pulmonary tuberculosis].
    Gyselen A; Cosemans J; Lacquet L; Verbist L
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):128-35. PubMed ID: 4491709
    [No Abstract]   [Full Text] [Related]  

  • 13. Side effects during intermittent rifampicin and ethambutol treatment. A preliminary report.
    Guerra Sanz FJ
    Scand J Respir Dis Suppl; 1973; 84():160-5. PubMed ID: 4522071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rifampicin combined with ethambutol and other antitubercular agents in the treatment of patients with chronic pulmonary tuberculosis. Early results. II. Analysis of causes of treatment interruption].
    Masztalerz J
    Pneumonol Pol; 1976 Feb; 44(2):153-61. PubMed ID: 940788
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proceedings: Preliminary results of a 2-phase therapy with rifampicin, ethambutol and a third drug in chronic polyresistant tuberculoses].
    Neumeyer D; Anschel R; Eule H; Fichtner K; Ganguin HG; Pickroth G
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):135-8. PubMed ID: 4491710
    [No Abstract]   [Full Text] [Related]  

  • 16. [Retreatment of tuberculosis resistent to 1st and 2d line drugs with AMP rifomycin and ethambutol].
    Ibarra JP; Pińeyro J; Mello Aguerre M; Pintos Fuentes R; Trenchi A; Freijeiro R; Bazerque E
    Hoja Tisiol; 1970; 27(1):98-117. PubMed ID: 5524669
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rifampicin and ethambutol in the treatment of chronic, destructive forms of pulmonary tuberculosis].
    Chmelev NA; Korotajev GA; Kaminskaja AA
    G Ital Chemioter; 1972; 19(2):1-6. PubMed ID: 4579712
    [No Abstract]   [Full Text] [Related]  

  • 18. Rifampicin and ethambutol in retreatment of chronic pulmonary tuberculosis.
    Wiman LG; Johansson R; Tegner KB
    Scand J Respir Dis; 1973; 54(5):255-63. PubMed ID: 4777378
    [No Abstract]   [Full Text] [Related]  

  • 19. [A comparative study on clinical efficacy of rifampicin (RFP), ethambutol (EB) and ethionamide (1321 TH) in retreatment of pulmonary tuberculosis. Report of the 13th series study part B].
    Kekkaku; 1972 May; 47(5):139-44. PubMed ID: 5042532
    [No Abstract]   [Full Text] [Related]  

  • 20. [Causes of failure in neutralization, recovery and social rehabilitation of chronic eliminators of Koch bacilli treated with rifampin and ethambutol].
    Barbu Z; Alexa M; Josefovics F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):153-9. PubMed ID: 212812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.